![](/img/cover-not-exists.png)
52 Rapid and durable objective responses in patients with advanced non-small-cell lung cancer in phase II trials (IDEAL 1 and IDEAL 2) treated with gefitinib
U. Gatzemeier, J.Y. Douillard, M. Kris, M. Fukuoka, R. Herbst, J. Schiller, M. Wolf, A. McPartiane, A. Kay, A. FandiVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90087-5
File:
PDF, 170 KB
english, 2003